As the keynote speakers, Dr. John B Robbins, Senior Investigator, National Institute of Child Health & Human Development, National Institute of Health, 1996 Albert Lasker Medical Award Winner, USA; Dr. Michael Favorov, Director General, International Vaccine Institute (IVI), Korea; Dr. Katherine Cohen, VP, Corporate & Business Development, Intercell AG, Austria;made excellent presentations and warmly discussed with the audiences at keynote forum.

Totally, there were nearly 400 participants from more than 40 countries and areas have attended the WCV-2008. 48 sessions covered 6 fields including Public Health, Economics, Safety/ Ethic and Policy of Vaccination; Scientific & Technological Frontiers of Vaccines; Human Preventive and Therapeutic Vaccines-Future Vaccines; Other Human Vaccine Development; Vaccine R & D for Emerging Infectious Diseases; Livestock/Veterinary/ Aquaculture Vaccine R & D and so on. With a theme of “Build an Olympian Meeting Platform for Future Vaccine World”, participants from academic, industrial professionals and key-decision makers delivered the new achievement on their research, together discussed and analysised the development of vaccine. The conference has promoted the communication of colleagues and collaboration of partners from the upstream to the downstream of vaccine technology.

According to the investigation after the conference, over 70% participants expressed that they would like to attend WCV-2009. Depending on the warmly support and good suggestions from all of the participants, we are confident in organizing WCV-2009 which would be better and more successful than ibioWCV-2008.